Author:
Gibbons Jason Brian,Sugarman Olivia K.,Byrne Lauren,Harris Samantha J.,Shah Hridika,Hulsey Eric G.,Rwan Julie,Rosner Esther Mae,Pantaleo Anthony,Bergquist Emily,Saloner Brendan
Reference28 articles.
1. Naloxone co-dispensing with opioids: a cluster randomized pragmatic trial;Binswanger;J. Gen. Intern Med,2022
2. Pharmacist attitudes toward pharmacy-based naloxone: a cross-sectional survey study;Burstein;J. Am. Pharm. Assoc.,2020
3. Injection drug use frequency before and after take-home naloxone training;Colledge-Frisby;JAMA Netw. Open,2023
4. District Health Department, 2020. MDHHS and EMS Launch Naloxone Leave Behind Program. Available at https://www.dhd10.org/wp-content/uploads/2020/09/DHD10_PressRelease_NaloxoneLeaveBehindProgram_9.01.20.pdf. Accessed 10/3/2023.
5. Doleac, J.L., Mukherjee, A., 2016. The Moral Hazard of Lifesaving INnivations: Naloxone Access, Opioid Abuse, and Crime. IZA Institute of Labor Economics Discussion Paper Series. Available at https://docs.iza.org/dp11489.pdf. Accessed 7/22/2024.